Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Ruygrok

Showing results (31-40 of 43) with videos related to

Pageof 5
Sort By:
Circulation|July 8, 2010
B-type natriuretic peptide signal peptide circulates in human blood: evaluation as a potential biomarker of cardiac ischemiaMaithri Siriwardena, Torsten Kleffmann, Peter Ruygrok, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|July 21, 2012
Initial clinical experience with the Coherex FlatStent™ and FlatStent™ EF PFO closure system for in-tunnel PFO closure: results of the Coherex-EU studyHorst Sievert, Nina Wunderlich, Isabel Reiffenstein, et al.
Journal of the American College of Cardiology|July 31, 2010
Removal of contrast media from the coronary sinus attenuates renal injury after coronary angiography and interventionStephen J Duffy, Peter Ruygrok, Craig P Juergens, et al.
Journal of Inherited Metabolic Disease|October 9, 2016
Cardiomyopathy as presenting sign of glycogenin-1 deficiency-report of three cases and review of the literatureCarola Hedberg-Oldfors, Emma Glamuzina, Peter Ruygrok, et al.
Clinical Chemistry|February 26, 2003
Origin of plasma cell-free DNA after solid organ transplantationYanni Y N Lui, Kam-Sang Woo, Angela Y M Wang, et al.
JACC. Cardiovascular Interventions|May 26, 2009
The antiplatelet effect of higher loading and maintenance dose regimens of clopidogrel: the PRINC (Plavix Response in Coronary Intervention) trialPatrick Gladding, Mark Webster, Irene Zeng, et al.
JACC. Cardiovascular Interventions|May 26, 2009
The pharmacogenetics and pharmacodynamics of clopidogrel response: an analysis from the PRINC (Plavix Response in Coronary Intervention) trialPatrick Gladding, Mark Webster, Irene Zeng, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|January 13, 2009
Transcatheter closure of patent foramen ovale with radiofrequency: acute and intermediate term results in 144 patientsHorst Sievert, Peter Ruygrok, Matt Salkeld, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|September 17, 2009
A randomised comparison of an everolimus-eluting coronary stent with a paclitaxel-eluting coronary stent:the SPIRIT II trialPatrick W Serruys, Peter Ruygrok, Jörg Neuzner, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|August 7, 2010
Efficacy of everolimus eluting stent implantation in patients with calcified coronary culprit lesions: two-year angiographic and three-year clinical results from the SPIRIT II studyYoshinobu Onuma, Shuzou Tanimoto, Peter Ruygrok, et al.
Pageof 5

Showing results (31-40 of 43) with videos related to

Sort By:
Pageof 5
Circulation|July 8, 2010
B-type natriuretic peptide signal peptide circulates in human blood: evaluation as a potential biomarker of cardiac ischemiaMaithri Siriwardena, Torsten Kleffmann, Peter Ruygrok, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|July 21, 2012
Initial clinical experience with the Coherex FlatStent™ and FlatStent™ EF PFO closure system for in-tunnel PFO closure: results of the Coherex-EU studyHorst Sievert, Nina Wunderlich, Isabel Reiffenstein, et al.
Journal of the American College of Cardiology|July 31, 2010
Removal of contrast media from the coronary sinus attenuates renal injury after coronary angiography and interventionStephen J Duffy, Peter Ruygrok, Craig P Juergens, et al.
Journal of Inherited Metabolic Disease|October 9, 2016
Cardiomyopathy as presenting sign of glycogenin-1 deficiency-report of three cases and review of the literatureCarola Hedberg-Oldfors, Emma Glamuzina, Peter Ruygrok, et al.
Clinical Chemistry|February 26, 2003
Origin of plasma cell-free DNA after solid organ transplantationYanni Y N Lui, Kam-Sang Woo, Angela Y M Wang, et al.
JACC. Cardiovascular Interventions|May 26, 2009
The antiplatelet effect of higher loading and maintenance dose regimens of clopidogrel: the PRINC (Plavix Response in Coronary Intervention) trialPatrick Gladding, Mark Webster, Irene Zeng, et al.
JACC. Cardiovascular Interventions|May 26, 2009
The pharmacogenetics and pharmacodynamics of clopidogrel response: an analysis from the PRINC (Plavix Response in Coronary Intervention) trialPatrick Gladding, Mark Webster, Irene Zeng, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|January 13, 2009
Transcatheter closure of patent foramen ovale with radiofrequency: acute and intermediate term results in 144 patientsHorst Sievert, Peter Ruygrok, Matt Salkeld, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|September 17, 2009
A randomised comparison of an everolimus-eluting coronary stent with a paclitaxel-eluting coronary stent:the SPIRIT II trialPatrick W Serruys, Peter Ruygrok, Jörg Neuzner, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|August 7, 2010
Efficacy of everolimus eluting stent implantation in patients with calcified coronary culprit lesions: two-year angiographic and three-year clinical results from the SPIRIT II studyYoshinobu Onuma, Shuzou Tanimoto, Peter Ruygrok, et al.
Pageof 5